Regional Drug Formulary revisions
The medications listed below that have been approved by P&T for addition to our formulary. The paper manual is only updated annually. Please print memo and add to the front of your manuals.
- carboxymethylcellulose 1% (non-contract) to 0.5% (on contract) eye drops
- hexylresorcinol (Bradasol) to dequalinium (Dequadin) throat lozenges
- potassium phosphate 15 mmol/250ml D5W & 30 mmol/500mL D5W
- meperidine restrictions:
- The prevention and treatment of drug-induced or blood product-induced rigors (e.g., amphotericin B, platelets),
- Treatment of post-operative shivering, and
- Short-term pain management in individuals with normal renal, hepatic and CNS function where alterna-tive opioids are contraindicated (e.g., allergy), and
- do not exceed 600 mg/24 hours
- limit the duration of use to 48 hours
- Combivent Respimat
- Spiriva Respimat
- Advair/Wixela Diskus
Submitted by: Pharmacy Program
For more info. contact: Cécile Dumesnil 204-371-5952 or